Skip to main content
Fig. 3 | Journal of Neuroinflammation

Fig. 3

From: Decrease in naturally occurring antibodies against epitopes of Alzheimer’s disease (AD) risk gene products is associated with cognitive decline in AD

Fig. 3

Assessment of diagnostic utility of different panels of NAbs by ROC analysis. Different panels of NAbs could differentiate AD (A and B) or MCI (C and D) from age- and gender matched CN individuals with diagnostic utility. NAbs natural antibodies, AD Alzheimer’s disease, MCI mild cognitive impairment, CN cognitively normal controls, ROC receiver operating characteristics, AUC area under the curve

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094